Patent · US Expired

Adjuvants for rectal delivery of drug

US4425337A · kind A · utility

22Cited by
1References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 30, 1981
Grant dateJan 10, 1984
Priority date—
Expiry dateDec 30, 2001

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/54
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method and drug form enhancing the rate of absorption of a rectally administered drug from the rectal compartment into the blood stream of a warm blooded animal. The method includes the steps of preparing a drug form capable of being rectally administered. The drug form comprises a therapeutically effective unit dosage amount of a selected drug of the type which is capable of being absorbed into the blood stream from the rectal compartment and phenothiazines or salts thereof being present in the drug form in a sufficient amount to be effective in enhancing the drug absorption rate, when rectally administering the drug form to warm blooded animals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.